Main Menu

Cambia, BiOS, Patent Lens in the News

Public disclosure of biological sequences in global patent practice

World Patent Information, USA
December 1, 2015
A global Patent Sequence (PatSeq) Data platform can enable national and regional jurisdictions meet the public disclosure standards.

Gene patent practice across plant and human genomes

Nature Biotechnology, USA
October 8, 2015
Similarities and differences in gene patent practices across three major crop and human genomes are exposed

The patent bargain

Nature, USA
December 11, 2013
An open-source patent database highlights the need for more transparency worldwide.

Who’s patenting whose genome?

QUT, USA
December 7, 2013

Transparency tools in gene patenting for informing policy and practice

Nature Biotechnology, USA
December 6, 2013
The Supreme Court's decision in Myriad highlights the need for tools enabling nuanced and precise analysis of gene patents at the global level.

"Grist" focus on Innovation Cartography

Cambia Patent Lens, USA
October 28, 2013
A 16th-century Dutchman can tell us everything we need to know about GMO patents

Introducing "The Lens"

Cambia Patent Lens, Australia
February 25, 2013
The improved facility is here, check out the new features and update your bookmark

Cambia again ranked as one of the world's top NGOs

The Global Journal, USA
January 23, 2013

The hologenome: A new view of evolution

New Scientist magazine, USA
January 12, 2013
The hologenome theory of evolution, and its development by Cambia CEO Richard Jefferson, featured in the January 12th Cover Story of New Scientist magazine

Cambia is named to the list of World's Top 100 NGOs 2012 by The Global Journal

The Global Journal, USA
January 12, 2012
From the hundreds of thousands of Non-governmental organizations in the world, the Global Journal has selected the Top 100 based on impact, innovation, transparency, accountability and efficiency.

Q&A with Richard Jefferson - Stanford Social Innovation Review

Stanford Social Innovation Review, USA
February 14, 2011
Richard Jefferson believes that biotechnology can be used to benefit the poor and disenfranchised, but only if the R&D process is democratized so that everyone has access to critical scientific tools and technologies.

USPTO makes US Patent Data Publicly available

Open letter to Mr David Kappos, Director of USPTO, Australia
November 1, 2010

Richard Jefferson is interviewed by NewsClick, India

Newsclick (India), India
May 8, 2010
GM Foods and Bt Brinjal: Interview with Prof. Richard Jefferson, Cambia

Richard Jefferson interviewed on ABC Lateline

ABC Lateline, Australia
April 13, 2010
Patent battle brewing over plant genes

Patent literature and Innovation in Africa

Intellectual Property Watch, Kenya
October 19, 2009

Collaboration key to biological energy production

CIO, Australia
October 6, 2009

A Singular Victory for Open Innovation

Business Standard, India
August 5, 2009
Navigation of this complex [patent] landscape is set to become much easier and more promising.

New initiatives to cure diseases of the poor world, The Economist

The Economist, US
July 16, 2009
Several new initiatives have been announced that will help cure the diseases of the poor world. Among them is the new Initiative for Open Innovation.

The Initiative for Open Innovation (IOI) is officially launched!

IOI July 13 Press Release, Austria
July 13, 2009
CEO Richard Jefferson launches the Initiative for Open Innovation in a invited speech at the UN sponsored meeting on Intellectual Property and Public Policy Issues, in Geneva July 13 & 14.

Cambia at EPO's East Meets West Conference 2009

Cambia at EPO's East Meets West Conference 2009, Austria
May 1, 2009
Doug Ashton, Cambia's head of Patent Informatics, attended the 2009 East Meets West conference, hosted by the European Patent Organisation.

Professor Richard Jefferson – scientist on a mission

ABC Catalyst, Australia
March 26, 2009
...he went on to champion “open sourcing”, a belief that all scientific tools should be available for use by everybody

Patent Lens and IOI endorsed by WIPO

Letter of Endorsement, International
March 25, 2009
Cambia's Patent Lens and IOI endorsed by Francis Gurry, Director General of the World Intellectual Property Organization (WIPO)

Richard Jefferson Interviewed in Com Ciência

Com Ciência No. 102, Brazil
October 5, 2008
Brazil's leading online science journal interviews Richard Jefferson for a special issue on synthetic biology

Joint effort on patents

The Australian, Australia
September 24, 2008
CAMBIA and the Queensland University of Technology are collaborating in the cause of making the patent system easier to navigate across a range of areas ......

Richard Jefferson gives Keynote presentation at ABIC 2008

ABIC 2008, Ireland
August 25, 2008

Monty Says - Blog of Monty Widenius

Monty Says, USA
June 28, 2008
MySQL Founders Monty Widenius & David Axmark sponsor and support Patent Lens

The appeal of Jefferson's open source model

Business Standard, India
May 28, 2008
The current head of CSIR, Samir Brahmachari... believes that open source is a promising route to drug discovery and has been espousing the cause at public forums.

Firms Seek Patents on 'Climate Ready' Altered Crops

The Washington Post, USA
May 13, 2008
"...both sides have oversimplified the pros and cons of biotech crop patents."

India Takes an Open Source Approach to Drug Discovery

Cell, USA
April 18, 2008
“In biology we need new clarity in what’s out there [in terms of patented research], what’s coming down the turnpike, and the new legal and cultural instruments to get past them,” says [CAMBIA's CEO] Jefferson

News by year

Non-english news

News - Greatest Hits!

Below is a selection of the media pieces that best reflect the nature of our work from a scientific, IT and intellectual property perspective.

The Freedom to Innovate: A Privilege or a Right? (info)
Editorial of The Plant Cell, May 2007
"...efforts to make the claims of patents ... more transparent and navigable, such as the Patent Lens ...should be supported by all."

Google is Great, but the Patent Lens is Better
Tech LawForum, December 14, 2006
"Transparency in patents is a good idea others are getting into in a big way, but there's still room for mutual improvement."

Patently Transparent (info)
Nature Biotechnology , May 2006
"The ability to interpret and filter intellectual property (IP) has never been more important...Cambia's Patent Lens is a giant leap in the right direction"

Open Source BioTech
Red Herring,
April 11, 2006
"Patent transparency is the lifeblood of the new open source." In a feature edition, renowned IT mag Red Herring focuses on Cambia's role in pushing the boundaries of the biotech industry.

Navigating the Future(s) of Biotech Intellectual Property
Nature Biotechnology, March 8, 2006
What impact is open source having on the biotech IP system?

Open Source Biotech: Science as a Tool for Social Justice
Genome Canada's Bulletin,
July 1, 2005
"If you can't win the game, then change the rules. That could be the mantra of Cambia..."

Open-Source Practices for Biotechnology'
New York Times, February 10, 2005
A profile of BIOS including a discussion of the Nature publication.

Gene Transfer to Plants by Divers Species of Bacteria
Nature, February 10, 2005
Cambia researchers publish a groundbreaking study demonstrating the viability of non-Agrobacterium bacteria in plant gene transfer.